Delivery Order SPE2DB20D2104-SPE2DB23FV12V
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $4.8
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $41,110 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 10-11, 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $2,670 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in mid-September 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $38,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 6-7, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an existing...
- The Defense Logistics Agency awarded a $38,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 6-7, 2023. The firm fixed price contract was issued under DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $102 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet needs under the agency's pharmaceutical programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early September 2023. The firm fixed price contract type provides certainty of cost to the...
- The Defense Logistics Agency awarded a $30,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. The prime contractor will provide 5ml bottles of the 0.4% strength ophthalmic solution to support DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 5 to July 6, 2023. No set aside designation or subcontractors were identified. The DLA manages the global supply...
- The Defense Logistics Agency awarded a $51,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract to supply various pharmaceutical products and services to military treatment facilities. Amerisourcebergen will deliver 5mL bottles of the 0.4% ketorolac ophthalmic solution, manufactured at its facility in Conshohocken, Pennsylvania, with performance required by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ketorolac 0.5% ophthalmic solution in 5ml quantities, with a ceiling value of $2,271.18 under a firm fixed price contract structure. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,348.64 for Ketorolac 0.5% ophthalmic solution in 5ML units on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV12VDelivery Order
The Defense Logistics Agency awarded a $4,830 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 10mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 30 to August 31, 2023. The delivery order was issued under DLA's pharmaceuticals and medical/surgical supply vehicle, which provides critical medicines and medical supplies to support the Department of Defense's readiness and healthcare missions. No subcontractors or set aside designations were identified.
Generated 12/20/23, 5:13 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5 | 8/30/23 |